Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Papillomavirus Infections × 30 days × Clear all

Phase

Status

Sponsor Class

OTHER 8 NIH 3 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 227 Neoplasms 157 Breast Neoplasms 142 Neoplasm Metastasis 95 Colorectal Neoplasms 95 Prostatic Neoplasms 85 Multiple Myeloma 82 Ovarian Neoplasms 78 Recurrence 73 Lung Neoplasms 73 Squamous Cell Carcinoma of Head and Neck 59 Pancreatic Neoplasms 51 Melanoma 51 Urinary Bladder Neoplasms 50 Stomach Neoplasms 50 Lymphoma, Non-Hodgkin 49 Endometrial Neoplasms 49 Leukemia, Lymphocytic, Chronic, B-Cell 48 Lymphoma, Large B-Cell, Diffuse 47 Leukemia, Myeloid, Acute 42 Carcinoma, Hepatocellular 41 Small Cell Lung Carcinoma 40 Carcinoma, Renal Cell 40 Triple Negative Breast Neoplasms 36 Uterine Cervical Neoplasms 31 Parkinson Disease 4, Autosomal Dominant Lewy Body 31 Glioblastoma 31 Lymphoma, Follicular 30 Esophageal Neoplasms 29 Glioma 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03903562 2026-04-06

V503-024

Merck Sharp & Dohme LLC

Phase 3 Completed

1,990 enrolled 42 charts

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡